EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)

Elijah R Behr iD, Bo Gregers Winkel iD, Bode Ensam iD, Alberto Alfie iD, Elena Arbelo iD, Colin Berry iD, Marina Cerrone iD, Giulio Conte iD, Lia Crotti iD, Cecilia M Gonzalez Corcia, Juan Carlos Kaski iD, Koonlawee Nademanee iD und 21 weitere

Europace · 2025

DOI: 10.1093/europace/euaf067 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Europace, 2025. Verfasst von Elijah R Behr und 32 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St. George's, University of London, Cranmer Terrace, Lond…. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Cardiac Electrophysiology, Death, Sudden, Cardiac, Electrophysiologic Techniques, Cardiac. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmacological provocation test is a pivotal tool in cardiac electrophysiology for the diagnosis of potential causes of sudden cardiac death, sudden cardiac arrest (SCA), arrhythmias, symptoms, or ECG abnormalities. The 2022 European Society of Cardiology Guidelines for the Treatment of Ventricular Arrhythmias and Prevention of Sudden Cardiac Death offered guidance on provocation testing but did not describe the indications and requirements in depth. This clinical consensus statement, led by the European Heart Rhythm Association and approved by major international stakeholders, aims to advise the general cardiologist and the arrhythmia expert who to test and when, where, and how to do it. The statement focuses on current practice for the diagnosis of subclinical arrhythmia syndromes and the causes of SCA, building upon the recommendations of the Guidelines. We address the sodium channel blocker provocation test for patients suspected of Brugada syndrome as well as the use of epinephrine, isoproterenol, adenosine, ergonovine, and acetylcholine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmias, CardiacCardiac ElectrophysiologyDeath, Sudden, CardiacElectrophysiologic Techniques, CardiacHumansConsensusElectrocardiographyPredictive Value of Tests

Stichwörter der Autor:innen

Brugada syndromeWolff-Parkinson-White syndromeacetylcholineadenosineajmalinecardiac arrestcatecholaminergic polymorphic ventricular tachycardiacoronary vasospasmdrug challengeepinephrineergonovineflecainideisoproterenolpilsicainideprocainamide

Autor:innen und Institutionen

  • Cardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St. George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.
  • Cardiology Care Group, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London, SW17 0QT, UK.
  • Mayo Clinic Healthcare, 15 Portland Place, London, W1B 1PT, UK.
  • Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.
  • University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.

ORCID-Profile: Elijah R Behr, Bo Gregers Winkel, Bode Ensam, Alberto Alfie, Elena Arbelo, Colin Berry, Marina Cerrone, Giulio Conte, Lia Crotti, Juan Carlos Kaski, Koonlawee Nademanee, Pieter G Postema, Silvia Priori, Vincent Probst, Georgia Sarquella-Brugada, Eric Schulze-Bahr, Rafik Tadros, Arthur Wilde, Jacob Tfelt-Hansen

Zitieren

APA

Behr, E. R., Winkel, B. G., Ensam, B., Alfie, A., Arbelo, E., Berry, C., Cerrone, M., Conte, G., Crotti, L., Corcia, C. M. G., Kaski, J. C., Nademanee, K., Postema, P. G., Priori, S., Probst, V., Sarquella-Brugada, G., Schulze-Bahr, E., Tadros, R., Wilde, A., …, & Veltmann, C. (2025). The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. https://doi.org/10.1093/europace/euaf067

Vancouver

Behr ER, Winkel BG, Ensam B, Alfie A, Arbelo E, Berry C, et al. The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2025. doi:10.1093/europace/euaf067

BibTeX
@article{Behr2025,
  author = {Behr, Elijah R and Winkel, Bo Gregers and Ensam, Bode and Alfie, Alberto and Arbelo, Elena and Berry, Colin and Cerrone, Marina and Conte, Giulio and Crotti, Lia and Corcia, Cecilia M Gonzalez and Kaski, Juan Carlos and Nademanee, Koonlawee and Postema, Pieter G and Priori, Silvia and Probst, Vincent and Sarquella-Brugada, Georgia and Schulze-Bahr, Eric and Tadros, Rafik and Wilde, Arthur and Tfelt-Hansen, Jacob and Wolpert, Christian and Cuesta, Alejandro and Damman, Peter and Dobrev, Dobromir and Drago, Fabrizio and Haugaa, Kristina and Krahn, Andrew and Krause, Ulrich and Lambiase, Pier D and Napolitano, Carlo and Odening, Katja E and Shimizu, Wataru and Veltmann, Christian},
  title = {The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf067}
}
Kostenlos starten →